Last reviewed · How we verify

Systemic Chemotherapy — Competitive Intelligence Brief

Systemic Chemotherapy (Systemic Chemotherapy) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Cytotoxic agent. Area: Oncology.

phase 3 Cytotoxic agent Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Systemic Chemotherapy (Systemic Chemotherapy) — Second Affiliated Hospital, School of Medicine, Zhejiang University. Systemic chemotherapy involves the use of drugs to kill cancer cells throughout the body.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Systemic Chemotherapy TARGET Systemic Chemotherapy Second Affiliated Hospital, School of Medicine, Zhejiang University phase 3 Cytotoxic agent
Ethyl alcohol Ethyl alcohol South Egypt Cancer Institute marketed Cytotoxic agent / Sclerosing agent
Cyclophosphamide and azathioprine Cyclophosphamide and azathioprine Assistance Publique - Hôpitaux de Paris phase 3 Immunosuppressive agents / Cytotoxic agents

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Cytotoxic agent class)

  1. Blanchette Rockefeller Neurosciences Insitute · 1 drug in this class
  2. Second Affiliated Hospital, School of Medicine, Zhejiang University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Systemic Chemotherapy — Competitive Intelligence Brief. https://druglandscape.com/ci/systemic-chemotherapy. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: